(Press-News.org)
Research from the Registro Nacional de Cáncer notes that Uruguay has the highest cancer incidence and mortality rates in Latin America. In particular, cervical cancer is the third leading cause of cancer related morbidity among Uruguay's female population.
To further motivate action to combat cervical cancer, BGI Genomics today released its State of Cervical Cancer Awareness Report in Uruguay. This report assesses the level of knowledge, attitudes, and practices related to cervical cancer screening and the human papillomavirus (HPV) vaccine. By examining these key areas, this survey seeks to highlight the associated barriers and opportunities. 1,878 female respondents from six countries and regions were surveyed: Brazil, the Chinese mainland, Saudi Arabia, Serbia, Thailand, and Uruguay.
In Uruguay, 68.6% of vaccinated women had a screening test which is lower than the global average of 82.1% of vaccinated women. HPV vaccination is a primary prevention intervention and does not eliminate the need for screening later in life since the existing vaccines do not protect against all high-risk HPV types and will have a limited impact on disease in unvaccinated women and those vaccinated at older ages.
Other key takeaways from the report include:
HPV awareness affects cervical cancer screening rates: Among women who are unaware cervical cancer is often caused by HPV, 39.1% of them never undertaken cervical cancer screening which is higher than the global average of 31.2%.
More choice, fewer barriers: Age-specific HPV prevalence was highest in young women (<25 years) at 22%. Yet, 43.5% of women aged 21 to 25 years old - highest among the age groups surveyed - are deterred by meeting a male doctor performing a pap smear. Therefore, women, especially young women, should be offered HPV DNA tests in addition to pap smear tests.
Vaccination and screening form a virtuous cycle: For women who had the HPV vaccine, 82.1% had a cervical cancer screening, significantly higher than 60.6% of unvaccinated women. For women who had undergone screening, 45.9% received the HPV vaccine, which is higher relative to 22.1% of unscreened women. Informing women who missed national vaccination programs about where and when they could get vaccinated and screened is vital.
"Early cervical cancer detection is vital to save lives and eventually eliminate this dreaded disease in line with WHO's global strategy," said Zhang Lin, BGI Genomics Senior Product Manager. "This study shows increased awareness of women could be the missing link to boost vaccination and screening rates further."
To read and view country or region-level comparisons, please see link to access the full BGI Genomics State of Cervical Cancer Awareness Report 2023.
About BGI Genomics
BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.
The CE-certified SENTIS™ HPV test combines self-sampling technology and genotyping assay to detect 14 most important, "high-risk" types of HPV, including HPV -16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and 2 "low-risk" types of the virus, HPV -6, 11. HPV genotyping detection is based on Next Generation Sequencing (NGS) technology based on a large sample volume for each run, which decreases the testing cost for each individual. The WHO recommends DNA testing as a first-choice screening method for cervical cancer prevention.
END
Although rare, mucosal melanoma in humans has a low survival rate. It has been difficult to investigate due to a lack of similar cancers in animals for study. Researchers explored a protein common to human and canine mucosal melanoma. The protein seems to be what makes this cancer so problematic, as it mobilizes the cancer cells, allowing them to spread. Researchers hope that eliminating this protein could lead to a potential treatment. The study is published in Molecular Cancer Research, a journal of the American Association for Cancer Research.
Melanoma is a type of cancer that begins in ...
As an electromechanical actuator, symmetric-actuating devices are often used in the fields where symmetrical motion, drive, and control are required, such as grasping or scissoring operations, and fast symmetric opening or closing of microchannels. One scenario with strong demand is minimally invasive surgery, including precision grasping and cutting tumor cells, retinal microsurgery, etc. In the field of micro electromechanical devices, the scissoring or grasping operation essentially belongs to two symmetrical actuations between two end-effectors. However, there is almost no one motor that can directly generate two symmetrical linear motions.
In general, to produce two symmetrical ...
DALLAS, July 26, 2023 — Existing research shows certain types of migraines can increase the risk of stroke, and there is growing evidence that they may also lead to other types of cardiovascular disease (CVD). To learn more about these connections, the American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, is providing a total of $2.1 million in grants for seven new scientific research projects. The selected teams of scientists for the “Migraine ...
NEW YORK, July 26, 2023 – The Blavatnik Family Foundation and the New York Academy of Sciences announced today the 2023 laureates of the Blavatnik National Awards for Young Scientists.
Each will receive $250,000, the largest unrestricted scientific award for America’s most innovative, faculty-ranked scientists and engineers who are under the age of 42. The winners and their distinguished research:
2023 Laureate in Life Sciences: William Anderegg, Ph.D., The University of Utah (Ecology & Evolutionary ...
Lymph nodes are one of the body’s first lines of defense against disease. Immune cells are dispatched from these biological police stations to fight off intruders. But somehow, lymph nodes are also the first stop for most metastatic cancers.
“It’s paradoxical,” Cold Spring Harbor Laboratory (CSHL) Assistant Professor Semir Beyaz says. “The cancer goes right in, but the immune cells aren’t doing anything. It’s important to understand what’s going on because this is how cancer takes the whole body hostage.”
Beyaz joined with collaborators from Massachusetts General Hospital to investigate. They ...
Researchers from WU Vienna University of Economics and Business, University of Bonn, and FAU Erlangen-Nürnberg published a new Journal of Marketing article that examines how consumers respond to new products co-developed with universities and the unique marketing opportunities for these products.
Firms often collaborate with universities to access novel scientific knowledge and technological expertise with an aim to develop superior new products. For example, Italian start-up Angles90 co-developed the first dynamic training grips with the faculty of Strength Training Ergonomics at the Technical University of ...
PULLMAN, Wash. –Sexual health, diet and exercise are the three topics that steal the show when it comes to popular health-related videos on TikTok. Unfortunately, there’s little else in terms of engaging health-related content on the video sharing platform, a Washington State University study found.
The social media platform’s mostly young audience also seems to prefer health-related videos featuring popular influencers’ role model appeals, such as their diet or exercise routine, rather than expert medical advice, ...
PARAMUS, N.J., July 26, 2023 – Octapharma USA today announced that Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) has received U.S. Food and Drug Administration (FDA) approval for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with need for urgent surgery or invasive procedures.
Balfaxar® helps restore blood coagulation by replenishing the levels of clotting factors that are deficient due to warfarin therapy. Balfaxar® ...
HOUSTON, GOLDEN, Colo. and WATERTOWN, Mass. ― The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.
The agreement brings together Nexo’s unique drug discovery platform, which combines innovative covalent chemistry and chemical biology, with the translational research and drug development expertise ...
Scientists have discovered the honey produced by Australian ants possesses unique anti-microbial activity against bacteria and fungi that could make the liquid useful medicinally.
The research, published today in PeerJ, was led by Andrew Dong and Dr Kenya Fernandes from the University of Sydney’s Carter Lab, which is led by Professor Dee Carter from the School of Life and Environmental Sciences and Sydney Institute for Infectious Diseases.
The team studied the Australian honeypot ant, Camponotus inflatus, which is found throughout desert areas mainly in Western Australia and the Northern Territory.
Among ...
